KimeraCHEMS- C
- N
- O
- F
Calculated reference model · not an experimental or batch-certified structure. All 25 atoms shown.
Model data & sources
- Heavy atoms only; hydrogens are omitted from the reference display.
- Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
- Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
- Formula
- C18H17F3N2O2
- Method
- RDKit ETKDGv3 / MMFF94s calculated reference conformer
- Batch
- KC-J47-02
J-147
NootropicsPublished formats
- Powder 1g
- Dry-Fill Capsule 60ct/10mg/600mg
What is the difference between these?
- Powder
- Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
- Dry-Fill Capsule
- Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.
Pricing
Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.
Technical Specifications
Batch COA Database ↗Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.
Research Overview
J-147 (Trifluoroacetamide Hydrazone)
J-147 is a synthetic trifluoroacetamide hydrazone originally developed at the Salk Institute (Schubert Laboratory). Derived from a curcumin-based screening series, J-147 was specifically engineered to address the inherent metabolic instability and poor bioavailability of the curcumin scaffold. By integrating a trifluoromethyl group, researchers successfully created a compound that retains the pharmacophore while significantly improving metabolic profile.
Physical & Handling Properties
| Property | Specification |
|---|---|
| Appearance | White to off-white crystalline solid |
Mechanism of Action & Scientific Context
J-147 was identified through phenotypic screening in cell-based assays of neuronal survival rather than target-directed design. Subsequent drug-affinity chromatography identified the α-subunit of mitochondrial ATP synthase (ATP5A) as a primary binding partner.
Mechanism Clarification:
J-147 is not a mitochondrial enhancer. Research indicates it acts as a partial inhibitor of ATP synthase activity. The observed biological effects are not a result of increased energy production, but rather an adaptive, AMPK-dependent stress response triggered by the cell in response to the mild reduction in mitochondrial respiration.
Primary fields of in vitro laboratory investigation include:
-
ATP Synthase Binding: Mapping target-engagement and binding kinetics with the ATP5A subunit.
-
Mitochondrial Respirometry: Measuring oxygen consumption rates and membrane potential under controlled conditions.
-
AMPK Signaling: Analyzing cellular stress-response pathways.
-
Neuronal Cytoprotection: Utilizing cell culture models to assess protective mechanisms.
-
Comparative SAR: Assessing the structure-activity relationship across curcumin-derivative series.
Storage & Handling Guidelines
Store at controlled room temperature. Keep tightly closed.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
Related Research Compounds
Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.
Certificates of Analysis
- Batch KC-J47-02 1 report
- Batch KC-J47-01 2 reports
Currently shipping from batch KC-J47-02.
Compounds That Survive Scrutiny
Research use only. Not for human or veterinary use.